FHTX 8-K 2026-10-01

Foghorn Therapeutics Inc. (FHTX) 8-K dated 2026-10-01 — accession 0001628280-26-064102. This URL is the filing, not the FHTX hub.

Foghorn Therapeutics Inc. (FHTX) is a biotechnology company listed on NASDAQ.

Foghorn Therapeutics Inc. filed a 8-K on 2026-10-01. Accession 0001628280-26-064102.

Cached items: 2.05, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported FHTX revenue for 2025-12-31 was $30.9M. Net income was -$74.3M. Revenue was up 36.8% from 2024-12-31 to 2025-12-31. FHTX currently screens at market cap $237.8M.

Not investment advice. The FHTX SEC hub lists recent forms. The stock page is the research view.